Gianna F Mastrofini

Ms. Gianna F Mastrofini

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
JAJose Antonio
Jose Antonio
BABrandi Antonio
Brandi Antonio
SAShawn M. Arent
Shawn M. Arent
Darren CandowDarren Candow
Darren Candow
GEGuillermo Escalante
Guillermo Escalante
Adam WellsAdam Wells
Adam Wells
Energy drinks are a commonly consumed beverage, and studies suggest a possible performance-enhancing effect. A Google Scholar search using the keywords “energy drinks” and “exercise” yields numerous results, underscoring the voluminous research on this topic. However, there are questions regarding the effectiveness and safety of energy drinks. These questions include, but are not limited to: (1) What are the main active ingredients in energy drinks? (2) Do energy drinks assist in weight management? (3) Do energy drinks enhance aerobic performance? (4) Do energy drinks enhance athletic speed? (5) Do energy drinks improve reaction time? (6) Do energy drinks enhance lean tissue mass? (7) Can energy drinks improve cognitive performance? (8) Does the acute consumption of energy drinks elevate resting energy expenditure? (9) Is there any evidence to suggest that energy drinks are more effective than an identical serving of caffeine alone? (10) Are there sex differences in the response to energy drink consumption? (11) Do energy drinks affect sleep or sleepiness? (12) Should pregnant women avoid energy drinks? (13) Do energy drinks adversely affect cardiovascular function? (14) Does consuming energy drinks cause brain damage? (15) What are other safety considerations regarding energy drinks? (16) Is there any evidence to suggest that energy drinks are more effective than an identical serving of caffeine alone? (17) If caffeine is the main active ingredient in energy drinks and coffee, why is there a discrepancy in the adverse events reported for each? To address these questions, we performed an evidence-based scientific evaluation of the literature on energy drink supplementation.

20 January 2023 in Journal of Human Kinetics
Verified
Journal Article
Open access
MSMadelin R. Siedler
Madelin R. Siedler
MLMegan H. Lewis
Megan H. Lewis
ETEric T. Trexler
Eric T. Trexler
PLPriscila Lamadrid
Priscila Lamadrid
BWBrian J. Waddell
Brian J. Waddell
BCBill I Campbell
Bill I Campbell
The purpose of this study was to examine the effects of intermittent versus continuous energy restriction on body composition, resting metabolic rate, and eating behaviors in resistance-trained females. Thirty-eight resistance-trained females (mean ± standard deviation age: 22.3±4.2 years) were randomized to receive either six weeks of a continuous 25% reduction in energy intake (n= 18), or one week of energy balance after every two weeks of 25% energy restriction (eight weeks total; n= 20). Participants were instructed to ingest 1.8 g protein/kilogram bodyweight per day and completed three weekly supervised resistance training sessions throughout the intervention. There were no differences between groups for changes over time in body composition, resting metabolic rate, or seven of the eight measured eating behavior variables (p > 0.05). However, a significant group-by-time interaction for disinhibition (p < 0.01) from the Three-Factor Eating Questionnaire was observed, with values (± standard error) in the continuous group increasing from 4.91 ± 0.73 to 6.17 ± 0.71, while values in the intermittent group decreased from 6.80 ± 0.68 to 6.05 ± 0.68. Thus, diet breaks do not appear to induce improvements in body composition or metabolic rate in comparison with continuous energy restriction over six weeks of dieting, but may be employed for those who desire a short-term break from an energy-restricted diet without fear of fat regain. While diet breaks may reduce the impact of prolonged energy restriction on measures of disinhibition, they also require a longer time period that may be less appealing for some individuals.

GMGianna F Mastrofini
Gianna F Mastrofini
BMBridget A. McFadden
Bridget A. McFadden
ACAlexa Chandler
Alexa Chandler
BLBlaine S. Lints
Blaine S. Lints
HCHarry Cintineo
Harry Cintineo
SAShawn M. Arent
Shawn M. Arent
Cannabidiol (CBD) is a non-psychoactive phyto-cannabinoid derived from the Cannabis sativa plant. CBD exhibits various interactions at receptor sites, prompting the research of its potential anti-inflammatory, immunomodulatory, psychological, and pain-relieving effects. This study aimed to investigate the physiological, biochemical, and psychometric effects of a brand-specific, hemp-derived CBD product in healthy adults over a 12-week observation period. 54 healthy males and females (age = 25 ± 7y; BMI = 24.82 ± 3.25 kg/m2) recruited from a large Southeastern University completed the study. Participants arrived at the laboratory after > 8 h of fasting, and > 48 h without alcohol consumption and vigorous exercise. Following baseline measurements (height, weight, blood pressure, electrocardiogram (ECG), and blood work), participants were stratified by sex and randomized to either CBD or placebo groups. Products were administered double-blinded, with both given in liquid form containing medium-chain triglyceride oil, while the CBD product specifically contained 50 mg/mL of CBD. Participants were instructed to consume 1 mL of their product twice daily and were given enough product to last until their next laboratory visit. Data were collected at baseline and on days 30 ± 3, 60 ± 3, and 90 ± 3. Blood was drawn for analysis of immune and inflammatory biomarkers. Chronic pain among participants was calculated using urine samples according to the foundational pain index (FPI). Self-reported psychometric questionnaires were utilized (Cohen's Perceived Stress Scale, Pittsburgh Sleep Quality Index, Profile of Mood States,10-item Likert scale for perceived pain) to assess stress, sleep quality, mood state, and body discomfort. To determine overall wellbeing, participants completed a daily survey indicating if they missed work or school due to illness. Change from baseline was calculated for each measure, and mixed effects models were used to determine differences between groups over time while adjusting for baseline values (α = 0.05). Data are presented as mean ± standard deviation. There were no Group-by-Time interactions or Group or Time main effects for immune or inflammatory biomarkers (p > 0.05). Analyses revealed no Group-by-Time interactions or main effects observed for perceived stress, sleep quality, overall mood disturbance, and all the profile of mood state subscales (p > 0.05), except "vigor-activity." A Time main effect was found for the sub-score for "vigor-activity" (p = 0.007; Pre CBD = 19.5 ± 5.2, Post CBD = 17.3 ± 5.3; Pre PL = 19.0 ± 5.7, Post PL = 17.9 ± 7.1), which decreased from Visit 3 to Visit 4 (p = 0.025) and from Visit 3 to Visit 5 (p = 0.014). There was a Group main effect for FPI (p = 0.028; Pre CBD = 11.9 ± 14.4, Post CBD = 8.8 ± 10.9; Pre PL = 9.0 ± 14.2, Post PL = 12.9 ± 11.5), indicating that the placebo group had greater increases in pain over the intervention compared to the CBD group. No significant differences were found between groups in the incidence and prevalence of "colds or flus" (p > 0.05). CBD was safe and well tolerated in healthy adults. These findings show pain was lower in the CBD group, suggesting a potentially positive effect for consumption of CBD. "Vigor-activity" decreased across the intervention, which may be a confounding effect of the academic semester. While the dosage chosen was safe, more research may be warranted using higher doses as these may be needed to observe further therapeutic effects in healthy populations.

25 January 2022 in Psychology of Sport and Exercise
Verified
Journal Article
Closed access
GMGianna F Mastrofini
Gianna F Mastrofini
RCRobert P. Collins
Robert P. Collins
ARAlanis P. Rosado
Alanis P. Rosado
RTRalph C. Tauran
Ralph C. Tauran
AFAbby R. Fleming
Abby R. Fleming
MKMarcus W. Kilpatrick
Marcus W. Kilpatrick

BLBlaine S. Lints
Blaine S. Lints
AHAdam Harrison
Adam Harrison
SSSten O. Stray-Gundersen
Sten O. Stray-Gundersen
GMGianna F Mastrofini
Gianna F Mastrofini
RRRiccardo F. Romersi
Riccardo F. Romersi
SAShawn M. Arent
Shawn M. Arent
Optimizing human performance under stressful physical and cognitive conditions is paramount during high-stakes military operations. As such, interventions to improve warfighter performance by mitigating task-induced cognitive performance deficits are necessary. While caffeine is the most widely consumed psychoactive substance in the world, common side effects (i.e. anxiousness, micro-saccades, irritability) may be detrimental to warfighter operations. Theacrine, a purine alkaloid similar in structure to caffeine but with a longer half-life, less habituation, and fewer side effects, is proposed as a caffeine-alternative to enhance cognitive resilience. Tactically trained participants (n = 20; F = 5; M = 16; age = 21.5 ± 3.8 y) completed one baseline and three experimental visits. Baseline included familiarization with cognitive tasks and a graded exercise test to determine VO2max. Experimental sessions, separated by ≥96 hours, were double-blind, placebo-controlled, and randomized. Participants completed cognitive testing (Dynavision, Trazer, Object Hit and Avoid, Anti-Saccade, Two-Back), consumed either 300 mg caffeine (CAF), 150 mg caffeine +150 mg theacrine (CTC), or placebo (PLA), and repeated cognitive tests 60-min post supplementation. After a high-intensity interval exercise session (10 intervals at >90% VO2max with recovery), reaction time (RT) tests were repeated after the 4th and 8th intervals, as well as immediately and 30-min post-exercise. Heart rate was measured continuously. Change scores were calculated from baseline, and data analyzed using repeated measures ANOVA (α = 0.05) with Bonferroni correction. Both CAF and CTC consistently enhanced cognitive and physical performance compared to PLA. In the Two-Back task, CTC showed significantly higher total accuracy (p < 0.01), while both CAF and CTC had fewer target (p < 0.01) and non-target errors (CAF: p = 0.03; CTC: p < 0.01) than PLA. CTC also had significantly faster RTs (p = 0.03) and lower RT variability for non-target trials compared to both PLA and CAF (p < 0.01). For the Dynavision Go/NoGo task, both CTC (p = 0.01) and CAF (p = 0.03) had significantly faster RTs than PLA, regardless of time point. Post-exercise, accuracy (p = 0.01) and RTs (p < 0.01) improved significantly compared to post-supplement. In the Object Hit & Avoid task, CAF and CTC significantly improved task accuracy (p < 0.01) while reducing omission (p < 0.01) and commission errors (p < 0.01) compared to PLA. HRV measures (RMSSD, NN intervals, SDNN) significantly increased post-supplementation (p < 0.01) but decreased immediately (p < 0.01) and 30 min post-exercise (p < 0.01). Blood lactate significantly declined at 5 (p < 0.01) and 10 min (p < 0.01) post-exercise compared to immediately post-exercise. SIngestion of CAF and CTC improved various measures of cognitive performance before, and after fatiguing exercise. Furthermore, CTC had additional cognitive benefits beyond CAF. Thus, combining lower-dose caffeine and theacrine may improve cognitive-behavioral performance before and after fatiguing exercise to an equal or greater degree than higher doses of caffeine alone. This combination offers a non-pharmacological intervention for those who experience side effects with caffeine to mitigate the impact of physical and cognitive stress. Future research should examine higher doses of theacrine alone or with caffeine, chronic supplementation, extended exercise durations, and different cognitive metrics under varied stress and environmental conditions.